These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy]. Iutskovskiĭ AD; Fedotov VP; Leshchenko GM Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804 [No Abstract] [Full Text] [Related]
4. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology]. Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189 [No Abstract] [Full Text] [Related]
5. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin]. Sarkisian SV Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010 [TBL] [Abstract][Full Text] [Related]
6. [The effect of vilozen on the immune status of erysipelas patients and the prospects for its use for the immune rehabilitation of convalescents]. Frolov VM; Peresadin NA; Pinskiĭ LL; Korobka IuN Lik Sprava; 1992; (11-12):102-4. PubMed ID: 1292201 [No Abstract] [Full Text] [Related]
7. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients. Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749 [TBL] [Abstract][Full Text] [Related]
8. [T-activin in the treatment of patients with recurrent aphthous stomatitis]. Terekhova NV; Khazanova VV; Zemskaia EA; Bykova IA; Filonenko OF; Kosorukova NIa; Rabinovich IM Stomatologiia (Mosk); 1991; (2):35-7. PubMed ID: 1853375 [TBL] [Abstract][Full Text] [Related]
9. [A case of tactivin side effects in patient with eczema]. Zaerko VV Klin Med (Mosk); 1991 May; 69(5):97-8. PubMed ID: 1857089 [No Abstract] [Full Text] [Related]
10. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases]. Iakhontova OI; Dudanova OP; Khavinson VKh Sov Med; 1990; (6):85-8. PubMed ID: 2396134 [No Abstract] [Full Text] [Related]
11. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients]. Ianiushina VV Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674 [TBL] [Abstract][Full Text] [Related]
12. [Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin]. Chuvirov GN; Markova TP Ter Arkh; 1986; 58(9):67-70. PubMed ID: 3787495 [TBL] [Abstract][Full Text] [Related]
13. [The diagnostic and prognostic significance of the level of circulating immune complexes in patients with recurrent erysipelas]. Frolov VM; Boĭchenko PK; Peresadin NA Vrach Delo; 1990 Jun; (6):116-8. PubMed ID: 2399704 [TBL] [Abstract][Full Text] [Related]
14. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter]. Balabolkin MI; Arion VIa; Petunina NA Sov Med; 1987; (12):32-5. PubMed ID: 3502197 [No Abstract] [Full Text] [Related]